谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A phase 2 trial of orelabrutinib showing promising efficacy and safety in patients with persistent or chronic primary immune thrombocytopenia

Shi Yan,Hu Zhou,Ruibin Huang,Fang Wang,Heng Mei,Lie Lin,Jingming Guo,Xin Zhou, Zhenyu Li, Yaorong Liu, Sichen Li, Wei Zhou,Yu Hou,Ming Hou

American journal of hematology（2024）

引用 0|浏览30
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要